Beaumont Interstitial Cystitis Clinical Research Network

博蒙特间质性膀胱炎临床研究网络

• 批准号: 6682670
• 负责人: KENNETH M PETERS
• 金额: $ 8.15万
• 依托单位: WILLIAM BEAUMONT HOSPITAL RESEARCH INST
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-01 至 2008-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6682670
• 关键词: clinical research; clinical trials; cooperative study; experimental designs; human subject; human therapy evaluation; implant; interdisciplinary collaboration; interstitial cystitis; medical outreach /case finding; morphine; neuroregulation; outcomes research; patient oriented research; sign /symptom; statistics /biometry; urinary tract disorder chemotherapy

DESCRIPTION (provided by applicant): The objective is to work in a collaborative effort with other centers of excellence to develop and execute clinical trials for the treatment of interstitial cystitis. Established mechanisms are in place at William Beaumont Hospital, Department of Urology for enrolling and retaining interstitial cystitis patients into clinical research trials. We will work closely with the Interstitial Cystitis Research Network (ICCRN), the Data Coordinating Center, the Steering committee members, and the Urological Chronic Pelvic Pain Syndromes collaborative group to develop clinical research protocols along with ancillary studies on IC. The specific aims are to determine the role of sacral nerve modulation in treating interstitial cystitis symptoms in established IC patients who have failed traditional medical management or in newly diagnosed IC patients who did not respond to an operative hydro distension and at least 6 months of standard IC therapy. Response rates of sacral nerve modulation in the established IC (> 12 months) and newly diagnosed (<12 months) will be compared. We will use the outcomes criteria already established by the Interstitial Cystitis Clinical Trials Group and in addition, Morphine Dose Equivalents will be monitored before and after permanent implantation of the neuro generator. Adverse events and complications will be monitored. Ancillary studies as agreed upon by the ICCRN will be carried out in conjunction with the clinical trial.

描述（由申请人提供）： 目的是与其他卓越中心进行协作，以开发和执行临床试验，以治疗间质膀胱炎。在泌尿外科的William Beaumont医院已建立了既定的机制，用于将间质膀胱炎患者纳入临床研究试验。我们将与间质性膀胱炎研究网络（ICCRN），数据协调中心，指导委员会成员以及泌尿外科慢性骨盆疼痛综合征协作小组紧密合作，以开发临床研究方案以及IC的辅助研究。具体目的是确定s骨神经调节在治疗传统医疗管理失败或未对手术性水力延伸和至少6个月的标准IC治疗的新诊断的IC患者中，在治疗间质性膀胱炎症状中的作用。将比较已建立的IC（> 12个月）和新诊断（<12个月）中s骨神经调节的反应率。我们将使用间质膀胱炎临床试验组已经建立的结果标准，此外，将在神经发电机永久植入之前和之后，将监测吗啡剂量当量。不良事件和并发症将受到监测。 ICCRN同意的辅助研究将与临床试验一起进行。